Opinion: Biopharmaceuticals prioritize studies on the economics of therapies
Health Economics and Outcomes (HEOR) studies are an essential, yet overlooked, component of drug development. Decentralized testing now makes things easier.
Opinion: Biopharmaceuticals prioritize studies on the economics of therapies Read More »